Survival of liver failure pigs by transplantation of reversibly immortalized human hepatocytes with Tamoxifen-mediated self-recombination>

Journal of Hepatology

Volumn 47, Issue 1, 2007, Pages 74-82

  Totsugawa, Toshinori ^a   Yong, Chen ^a   Rivas Carrillo, Jorge David ^a   Soto Gutierrez, Alejandro ^a   Navarro Alvarez, Nalú ^a   Noguchi, Hirofumi ^b   Okitsu, Teru ^c   Westerman, Karen A ^d   Kohara, Michinori ^e   Reth, Michael ^f   Tanaka, Noriaki ^a   Leboulch, Philippe ^d   Kobayashi, Naoya ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KYOTO UNIVERSITY HOSPITAL   (Japan)

^d HARVARD MEDICAL SCHOOL   (United States)

^e TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^f UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Acute liver failure; Hepatocyte transplantation; Hepatocytes; Reversible immortalization

Indexed keywords

ALBUMIN; COMPLEMENTARY DNA; CRE RECOMBINASE; ENHANCED GREEN FLUORESCENT PROTEIN; GALACTOSAMINE; HEPARIN; LIDOCAINE; RETROVIRUS VECTOR; TACROLIMUS; TAMOXIFEN; TELOMERASE REVERSE TRANSCRIPTASE; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOARTIFICIAL LIVER; CELL IMMORTALIZATION; CELL SELECTION; CONTROLLED STUDY; DRUG METABOLISM; GENETIC RECOMBINATION; HEPATOCYTE TRANSPLANTATION; HUMAN; HUMAN CELL; LIVER FAILURE; LIVER TRANSPLANTATION; LOXP SITE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL;

ANIMALS; BIOLOGICAL MARKERS; CELL LINE, TRANSFORMED; HEPATOCYTES; HUMANS; INTEGRASES; LIVER FAILURE; RECOMBINATION, GENETIC; RETROVIRIDAE; SUS SCROFA; TAMOXIFEN; TREATMENT OUTCOME;

EID: 34249277092     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2007.02.019     Document Type: Article

References (27)

1. Ostapowicz G., Fontana R.J., Schiodt F.V., Larson A., Davern T.J., Han S.H., et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 137 (2002) 947-954
2. Bismuth H., Samuel D., Castaing D., Adam R., Saliba F., Johann M., et al. Orthotopic liver transplantation in fulminant and subfulminant hepatitis: the Paul Brousse experience. Ann Surg 222 (1995) 109-119
3. Berry M.N., and Friend D.S. High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study. J Cell Biol 43 (1969) 506-520
4. Stockmann H.B., and IJzermans J.N. Prospects for the temporary treatment of acute liver failure. Eur J Gastroenterol Hepatol 14 (2002) 195-203
5. Horslen S.P., Sudan D.L., Iyer K.R., Kaufman S.S., Iverson A.K., Fox I.J., et al. Isolated liver transplantation in infants with end-stage liver disease associated with short bowel syndrome. Ann Surg 235 (2002) 435-439
6. Kobayashi N., Ito M., Nakamura J., Cai J., Gao C., Hammel J.M., et al. Hepatocyte transplantation in rats with decompensated cirrhosis. Hepatology 31 (2000) 851-857
7. Fox I.J., Chowdhury J.R., Kaufman S.S., Goertzen T.C., Chowdhury N.R., Warkentin P.I., et al. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med 338 (1998) 1422-1426
8. Horslen S.P., McCowan T.C., Goertzen T.C., Warkentin P.I., Cai H.B., Strom S.C., et al. Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder. Pediatrics 111 (2003) 1262-1267
9. Strom S.C., Chowdhury J.R., and Fox I.J. Hepatocyte transplantation for the treatment of human disease. Semin Liver Dis 19 (1999) 39-48 1999
10. Westerman K.A., and Leboulch P. Reversible immortalization of mammalian cells mediated by retroviral transfer and site-specific recombination. Proc Natl Acad Sci USA 93 (1996) 8971-8976
11. Kobayashi N., Fujiwara T., Westerman K.A., Inoue Y., Sakaguchi M., Noguchi H., et al. Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes. Science 287 (2000) 1258-1262
12. Berghella L., De Angelis L., Coletta M., Berarducci B., Sonnino C., Salvatori G., et al. Reversible immortalization of human myogenic cells by site-specific excision of a retrovirally transferred oncogene. Hum Gene Ther 10 (1999) 1607-1617 1999
13. Salmon P., Oberholzer J., Occhiodoro T., Morel P., Lou J., and Trono D. Reversible immortalization of human primary cells by lentivector-mediated transfer of specific genes. Mol Ther 2 (2000) 404-414
14. Noguchi H., Kobayashi N., Westerman K.A., Sakaguchi M., Okitsu T., Totsugawa T., et al. Controlled expansion of human endothelial cell populations by Cre/LoxP-based reversible immortalization. Hum Gene Ther 13 (2000) 321-334
15. Watanabe T Shibata N., Westerman K.A., Okitsu T., Allain J.E., Sakaguchi M., et al. Establishment of immortalized human hepatic stellate scavenger cells to develop bioartificial livers. Transplantation 75 (2003) 1873-1880
16. Zhang Y., Riesterer C., Ayrall A.M., Sablitzky F., Littlewood T.D., Reth M., et al. Inducible site-directed recombination in mouse embryonic stem cells. Nucleic Acids Res 24 (1996) 543-548
17. Nakabayashi H., Taketa K., Miyano K., Yamane T., and Sato J. Growth of human hepatoma cell lines with differentiated functions in chemically defined medium. Cancer Res 42 (1982) 3858-3863
18. Alexander J.J., Bey E.M., Geddes E.W., and Lecatsas G. Establishment of a continuously growing cell line from primary carcinoma of the liver. S Afr Med J 50 (1976) 2124-2128
19. Kunieda T., Kobayashi N., Sakaguchi M., Okitsu T., Totsugawa T., Watanabe T., et al. Transduction of immortalized human hepatocytes with p21 to enhance differentiated phenotypes. Cell Transplant 11 (2002) 421-428
20. Maruyama M., Totsugawa T., Kunieda T., Okitsu T., Shibata N., Takesue M., et al. Hepatocyte isolation and transplantation in the pig. Cell Transplant 12 (2003) 593-598
21. Wege H., Le H.T., Chui M.S., Liu L., Wu J., Giri R., et al. Telomerase reconstitution immortalizes human fetal hepatocytes without disrupting their differentiation potential. Gastroenterology 124 (2003) 432-444
22. Gaines P., and Wojchowski D.M. pIRES-CD4t, a dicistronic expression vector for MACS- or FACS-based selection of transfected cells. Biotechniques 26 (1999) 683-688
23. Peitz M., Pfannkuche K., Rajewsky K., and Edenhofer F. Ability of the hydrophobic FGF and basic TAT peptides to promote cellular uptake of recombinant Cre recombinase: a tool for efficient genetic engineering of mammalian genomes. Proc Natl Acad Sci USA 99 (2002) 4489-4494
24. Okitsu T., Kobayashi N., Jun H.S., Shin S., Kim S.J., Han J., et al. Transplantation of reversibly immortalized insulin-secreting human hepatocytes controls diabetes in pancreatectomized pigs. Diabetes 53 (2004) 105-112
25. Guha C., Shah S.J., Ghosh S.S., Lee S.W., Roy-Chowdhury N., and Roy-Chowdhury J. Molecular therapies for viral hepatitis. BioDrugs 17 (2003) 81-91
26. Mehal W.Z., Azzaroli F., and Crispe I.N. Antigen presentation by liver cells controls intrahepatic T cell trapping, whereas bone marrow-derived cells preferentially promote intrahepatic T cell apoptosis. J Immunol 167 (2001) 667-673
27. Kobayashi N., Noguchi H., Totsugawa T., Watanabe T., Matsumura T., Fujiwara T., et al. Insertion of a suicide gene into an immortalized human hepatocyte cell line. Cell Transplant 10 (2001) 373-376